44 Result(s)

Article

Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costs

We report the first randomized study comparing early hospital discharge with standard hospital-based follow-up after high-dose chemotherapy (HDCT) and PBSCT. Patients aged 18–65 years, with an indication of PB...

C Faucher, A G Le Corroller Soriano, B Esterni, N Vey… in Bone Marrow Transplantation (2012)

Article

A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma

The potential benefit of rituximab as adjuvant to high-dose therapy (HDT) has been investigated in patients under 60 years with poor-risk (age-adjusted international prognostic index at 2–3) CD20+ diffuse larg...

D Coso, C Sebban, O Boulat, P Biron, J Rey, T Aurran… in Bone Marrow Transplantation (2006)

Article

Early administration of recombinant erythropoietin improves hemoglobin recovery after reduced intensity conditioned allogeneic stem cell transplantation

The use of recombinant human erythropoietin (rHuEPO) has been controversial after myeloablative allogeneic Stem cell transplantation (allo-SCT). Reduced intensity conditioning regimens (RIC) offer a novel appr...

V Ivanov, C Faucher, M Mohty, K Bilger, P Ladaique, D Sainty… in Bone Marrow Transplantation (2005)

Article

Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantation

In all, 41 multiple myeloma (MM) patients received an antithymocyte globulin (ATG), fludarabine, and busulfan-based reduced intensity conditioning (RIC) for allogeneic stem cell transplantation (allo-SCT) from...

M Mohty, J M Boiron, G Damaj, A S Michallet, J O Bay… in Bone Marrow Transplantation (2004)

Article

Multivariate analysis of survival in inflammatory breast cancer: impact of intensity of chemotherapy in multimodality treatment

The prognosis of inflammatory breast cancer (IBC) is poor. We evaluated clinical and biopathological characteristics that could affect survival in 74 women with nonmetastatic IBC consecutively treated in our i...

F Bertucci, C Tarpin, E Charafe-Jauffret, V-J Bardou… in Bone Marrow Transplantation (2004)

Article

Autologous stem cell transplantation for acute myelogenous leukemia in first complete remission: a 6-year follow-up study of 101 patients from a single institution

The objective of the study was to assess the long-term outcome and impact of stem cell source in patients with acute myelogenous leukemia (AML) who received ASCT in first complete remission (CR). A total of 10...

N Vey, R Bouabdallah, A Stoppa, C Faucher, M Lafage… in Bone Marrow Transplantation (2004)

Article

Occult tumor cell contamination in patients with stage II/III breast cancer receiving sequential high-dose chemotherapy

The purpose of this study was to evaluate the presence of micrometastatic cells in the apheresis products from patients with breast cancer, and also to determine if repeated infusion of contaminated products h...

F Viret, C Chabannon, D Sainty, D Genre, A Gonçalves… in Bone Marrow Transplantation (2003)

Article

Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen

In the setting of reduced-intensity conditioning (RIC) regimens for allogeneic stem cell transplantation (allo-SCT), the epidemiology of transplant-related infections is still poorly defined. In 101 high-risk ...

M Mohty, W Jacot, C Faucher, J O Bay, C Zandotti, L Collet, B Choufi, K Bilger… in Leukemia (2003)

Article

Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation

Allogeneic peripheral blood stem cell transplantation (PBSCT) has emerged as an alternative to bone marrow transplantation. PBSCT can be associated with a higher incidence of chronic graft-versus-host disease ...

M Mohty, K Bilger, E Jourdan, M Kuentz, M Michallet, J H Bourhis, N Milpied… in Leukemia (2003)

Article

Cost–effectiveness of repeated aphereses in poor mobilizers undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation

C Chabannon, A-G Le Corroller, F Viret, C Eillen, C Faucher, J-P Moatti… in Leukemia (2003)

Article

Intensive sequential dose dense chemotherapy with stem cell support as first-line treatment in advanced ovarian carcinoma: a phase II study

From August 1995 to December 1997, 15 patients with stage III–IV ovarian cancer were treated with outpatient intensive chemotherapy with G-CSF and stem cell support. The first cycle consisted of cyclophophamid...

F Viret, F Bertucci, D Genre, G Gravis, C Chabannon, M Conte… in Bone Marrow Transplantation (2002)

Article

Features of large granular lymphocytes (LGL) expansion following allogeneic stem cell transplantation: a long-term analysis

Large granular lymphocyte (LGL) proliferation typically follows a chronic course during which major features are cytopenia and immune abnormalities. Elevated numbers of LGL were reported in a few cases followi...

M Mohty, C Faucher, N Vey, C Chabannon, D Sainty, C Arnoulet, B Gaugler… in Leukemia (2002)

Article

Modulations of dose intensity of doxorubicin and cyclophosphamide in association with G-CSF and peripheral blood stem cells in adjuvant chemotherapy for breast cancer: comparative evaluation of completion and safety of three intensive regimens

The aim of this study was to evaluate and to compare in terms of toxicity the modulations of dose intensity of cyclophosphamide and doxorubicin in adjuvant chemotherapy for high-risk breast cancer. Four cycles...

D Genre, P Viens, F Bertucci, C Chabannon, G Gravis… in Bone Marrow Transplantation (2002)

Article

Overexpression of erb B2 remains a major risk factor in non-metastatic breast cancers treated with high-dose alkylating agents and autologous stem cell transplantation

The importance of dose intensity has been strongly emphasized in high-risk breast cancer. Overexpression of erb B2 is clearly correlated with an overall poor prognosis which could be limited in patients receiv...

AC Braud, MP Mathoulin Portier, VJ Bardou, F Bertucci… in Bone Marrow Transplantation (2002)

Article

Large granular lymphocytes (LGL) following non-myeloablative allogeneic bone marrow transplantation: a case report

We report here the first case of large granular lymphocytes (LGL) expansion following non-myeloablative allo-BMT for chronic myeloid leukemia. We characterized the morphologic, phenotypic and functional featur...

M Mohty, C Faucher, B Gaugler, N Vey, D Sainty, C Arnoulet… in Bone Marrow Transplantation (2001)

Article

Autologous peripheral blood stem cell transplantation (PBSCT) in acute myeloid leukaemia (AML) in first complete remission (CR) a report of the BGMT cooperative group about 32 patients

Thirty-two patients < 55 year with AML in first complete remission underwent autologous peripheral blood stem cell transplantation (PBSCT). Before transplant, they were treated with one or two induction course...

F. Bauduer, C. Fabères, J. M. Boiron, D. Blaise, G. Marit… in Hematology and Cell Therapy (2000)

Article

High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation

New approaches using nonmyeloablative-conditioning regimens have been developed to cause minimal procedure-related toxicity. Such novel therapeutic options are being explored with good preliminary results conc...

M Mohty, C Faucher, N Vey, AM Stoppa, F Viret, I Chabbert… in Bone Marrow Transplantation (2000)

Article

High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results

The importance of dose intensity has been suggested in ovarian carcinoma. We retrospectively evaluated the long-term results of melphalan-based high-dose chemotherapy (HDC) with hematopoietic rescue in a unice...

F Bertucci, P Viens, JR Delpero, VJ Bardou, C Faucher… in Bone Marrow Transplantation (2000)

Article

Role of high-dose therapy and initial response in survival of poor-risk patients with aggressive non-Hodgkin's lymphoma: a retrospective series on 126 patients from a single center

It is now established that a subgroup of non-Hodgkin's lymphoma (NHL) patients probably benefit from high-dose therapy (HDT). We therefore retrospectively analyzed survival of 126 consecutive patients with lar...

R Bouabdallah, D Coso, R Costello, VJ Bardou, D Blaise… in Bone Marrow Transplantation (2000)

Article

Transplantation of allogeneic CD34⁺ blood cells in leukemia or lymphoma patients at high risk of GVHD

F Viret, C Chabannon, T Aurran-Schleinitz, D Reviron… in Bone Marrow Transplantation (1999)